Intuitive Surgical, Inc. $ISRG Stock: State Street Corp Reduces Position

State Street Corp cut its position in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 49.7% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 16,173,422 shares of the medical equipment provider’s stock after selling 15,952,658 shares during the period. State Street Corp owned approximately 4.67% of Intuitive Surgical worth $6,576,599,000 at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. Dogwood Wealth Management LLC lifted its holdings in shares of Intuitive Surgical by 178.3% during the third quarter. Dogwood Wealth Management LLC now owns 64 shares of the medical equipment provider’s stock worth $26,000 after purchasing an additional 41 shares during the period. North Point Portfolio Managers Corp OH purchased a new stake in Intuitive Surgical in the third quarter valued at approximately $27,000. John Boyer Inc. purchased a new stake in Intuitive Surgical in the third quarter valued at approximately $27,000. Compass Wealth Management LLC acquired a new position in Intuitive Surgical in the 3rd quarter worth approximately $29,000. Finally, Compass Financial Management LLC acquired a new position in Intuitive Surgical in the 2nd quarter worth approximately $30,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Mark Brosius sold 61 shares of the business’s stock in a transaction on Wednesday, October 28th. The shares were sold at an average price of $441.60, for a total value of $26,937.60. Following the completion of the transaction, the executive vice president directly owned 581 shares in the company, valued at $256,569.60. The trade was a 9.50% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the company’s stock in a transaction dated Tuesday, November 10th. The stock was sold at an average price of $458.15, for a total transaction of $183,260.00. Following the completion of the transaction, the executive vice president owned 6,236 shares of the company’s stock, valued at approximately $2,857,023.40. This trade represents a 6.03% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 39,363 shares of company stock worth $17,738,749. 0.60% of the stock is currently owned by insiders.

Intuitive Surgical Stock Down 2.0%

Intuitive Surgical stock opened at $399.06 on Friday. The business’s 50-day moving average price is $423.51 and its 200 day moving average price is $427.91. The firm has a market cap of $138.33 billion, a price-to-earnings ratio of 48.25, a price-to-earnings-growth ratio of 3.02 and a beta of 1.45. Intuitive Surgical, Inc. has a 52 week low of $328.57 and a 52 week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last announced its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The company had revenue of $3.05 billion during the quarter, compared to the consensus estimate of $2.91 billion. During the same period in the previous year, the company posted $2.40 earnings per share. Intuitive Surgical’s revenue for the quarter was up 21.7% on a year-over-year basis. Equities analysts expect that Intuitive Surgical, Inc. will post 9.37 EPS for the current year.

Key Intuitive Surgical News

Investors following ISRG have been watching these news items:

  • Positive Sentiment: A BTIG Research analyst reportedly expects ISRG shares to rise, providing a positive analyst signal; the headline does not specify a price target or the reasoning. BTIG analyst article
  • Neutral Sentiment: An executive sold 46 shares under a pre-arranged Rule 10b5-1 plan. The transaction was small and scheduled in advance, so it is a limited signal about management’s outlook. Insider-sale report
  • Negative Sentiment: ISRG was reported down 1.7% since its latest earnings report, suggesting the strong results have not yet translated into sustained share-price momentum. The article offers no fresh earnings-estimate change to clarify the potential for a rebound. Post-earnings performance article

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on ISRG shares. Barclays reissued an “overweight” rating and set a $500.00 price target (up from $485.00) on shares of Intuitive Surgical in a research report on Wednesday, October 21st. Mizuho dropped their price objective on shares of Intuitive Surgical from $415.00 to $400.00 and set a “neutral” rating on the stock in a report on Wednesday, October 21st. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Wednesday, October 21st. Piper Sandler reiterated an “overweight” rating on shares of Intuitive Surgical in a research note on Friday, August 21st. Finally, Wells Fargo & Company reiterated an “overweight” rating and issued a $486.00 price objective (down from $487.00) on shares of Intuitive Surgical in a research note on Wednesday, October 21st. One research analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $495.90.

Read Our Latest Research Report on Intuitive Surgical

Intuitive Surgical Company Profile

(Free Report)

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.

Featured Stories

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.